This company has been marked as potentially delisted and may not be actively trading. Horizon Therapeutics Public (HZNP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Horizon Therapeutics Public Short Interest DataHorizon Therapeutics Public (HZNP) has a short interest of 7.10 million shares. This marks a -25.11% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 2.50 million shares to cover all short positions.Current Short Interest7,100,000 sharesPrevious Short Interest9,480,000 sharesChange Vs. Previous Month-25.11%Dollar Volume Sold Short$818.70 millionShort Interest Ratio3.2 Days to CoverLast Record DateSeptember 15, 2023Outstanding Shares228,990,000 sharesPercentage of Shares Shorted3.10%Today's Trading Volume0 sharesAverage Trading Volume2,498,525 sharesToday's Volume Vs. Average0% Short Selling Horizon Therapeutics Public? Sign up to receive the latest short interest report for Horizon Therapeutics Public and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHZNP Short Interest Over TimeHZNP Days to Cover Over TimeHZNP Percentage of Float Shorted Over Time Horizon Therapeutics Public Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/20237,100,000 shares $818.70 million -25.1%N/A3.2 $115.31 8/31/20239,480,000 shares $1.07 billion +20.6%N/A4.1 $112.74 8/15/20237,860,000 shares $818.15 million -7.8%3.5%4.9 $104.09 7/31/20238,520,000 shares $854.30 million +28.1%3.8%3.8 $100.27 7/15/20236,650,000 shares $691.20 million +3.7%3.0%3 $103.94 6/30/20236,410,000 shares $659.27 million -8.2%N/A2.9 $102.85 6/15/20236,980,000 shares $707.14 million -4.0%N/A3.1 $101.31 5/31/20237,270,000 shares $727.22 million +4.6%N/A3.3 $100.03 5/15/20236,950,000 shares $780.14 million +5.8%N/A3 $112.25 4/30/20236,570,000 shares $730.32 million +67.2%N/A3.9 $111.16 Get the Latest News and Ratings for HZNP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Horizon Therapeutics Public and its competitors with MarketBeat's FREE daily newsletter. 4/15/20233,930,000 shares $438.59 million +4.2%N/A1.8 $111.60 3/31/20233,770,000 shares $411.46 million -6.7%N/A1.7 $109.14 3/15/20234,040,000 shares $442.26 million +23.9%N/A1.6 $109.47 2/28/20233,260,000 shares $356.94 million -3.3%N/A0.9 $109.49 2/15/20233,370,000 shares $369.62 million -1.5%N/A0.9 $109.68 1/31/20233,420,000 shares $375.24 million -37.0%1.5%0.8 $109.72 1/15/20235,430,000 shares $614.89 million -12.7%2.4%1.4 $113.24 12/30/20226,220,000 shares $707.84 million -6.6%2.8%1.6 $113.80 12/15/20226,660,000 shares $752.58 million +2.6%3.0%1.7 $113.00 11/30/20226,490,000 shares $650.88 million -7.2%2.9%2.2 $100.29 11/15/20226,990,000 shares $531.59 million -7.1%3.1%2.7 $76.05 10/31/20227,520,000 shares $468.65 million -11.1%3.4%2.7 $62.32 10/15/20228,460,000 shares $528.83 million +4.7%N/A2.8 $62.51 9/30/20228,080,000 shares $500.07 million +43.8%N/A2.8 $61.89 9/15/20225,620,000 shares $357.09 million +21.4%N/A2 $63.54 8/31/20224,630,000 shares $274.14 million -24.6%N/A1.8 $59.21 8/15/20226,140,000 shares $398.49 million -18.6%N/A2.4 $64.90 7/31/20227,540,000 shares $625.59 million +1.6%3.4%3.1 $82.97 7/15/20227,420,000 shares $612.37 million -1.1%3.3%3.7 $82.53 6/30/20227,500,000 shares $598.20 million +7.5%4.5%3.7 $79.76 6/15/20226,980,000 shares $575.64 million +7.6%4.2%3.5 $82.47 5/31/20226,490,000 shares $582.09 million -11.7%2.9%3.5 $89.69 5/15/20227,350,000 shares $664.66 million +20.3%3.3%3.9 $90.43 4/30/20226,110,000 shares $602.20 million -3.9%2.7%3.2 $98.56 4/15/20226,360,000 shares $740.05 million +6.0%2.8%3.7 $116.36 3/31/20226,000,000 shares $631.26 million +5.8%2.7%3.4 $105.21 3/15/20225,670,000 shares $585.48 million +13.9%2.5%3.5 $103.26 2/28/20224,980,000 shares $454.03 million -3.1%2.2%3 $91.17 2/15/20225,140,000 shares $504.59 million +40.4%2.3%3.2 $98.17 1/31/20223,660,000 shares $341.59 million -8.5%1.7%2.5 $93.33Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 1/15/20224,000,000 shares $364.40 million +10.2%1.8%2.5 $91.10 12/31/20213,630,000 shares $391.17 million -24.5%1.6%2.5 $107.76 12/15/20214,810,000 shares $513.37 million -10.3%2.2%3.2 $106.73 11/30/20215,360,000 shares $556.15 million -10.4%2.4%3.6 $103.76 11/15/20215,980,000 shares $654.87 million +0.7%2.7%4.4 $109.51 10/29/20215,940,000 shares $712.27 million +78.9%2.7%4.7 $119.91 10/15/20213,320,000 shares $372.11 million -11.5%1.5%2.9 $112.08 9/30/20213,750,000 shares $410.78 million -5.8%1.7%3.4 $109.54 9/15/20213,980,000 shares $422.16 million -2.7%1.8%3.4 $106.07 8/31/20214,090,000 shares $442.09 million +21.0%1.9%3.1 $108.09 8/13/20213,380,000 shares $360.71 million +1.2%1.5%2.3 $106.72 7/30/20213,340,000 shares $334.07 million +3.1%1.5%2.2 $100.02 7/15/20213,240,000 shares $305.40 million -3.6%1.5%2.1 $94.26 6/30/20213,360,000 shares $314.63 million -34.8%1.5%2.2 $93.64 6/15/20215,150,000 shares $470.20 million -9.0%2.3%3.2 $91.30 5/28/20215,660,000 shares $518.80 million -3.1%2.6%3.6 $91.66 5/14/20215,840,000 shares $512.40 million -3.3%N/A3.5 $87.74 4/30/20216,040,000 shares $571.99 million -3.1%N/A3.5 $94.70 4/15/20216,230,000 shares $569.73 million +8.0%N/A3.3 $91.45 3/31/20215,770,000 shares $502.74 million +4.5%N/A2.9 $87.13 3/15/20215,520,000 shares $506.63 million -18.9%N/A2.6 $91.78 2/26/20216,810,000 shares $616.78 million +4.1%N/A0 $90.57 2/12/20216,540,000 shares $596.12 million +20.9%N/A2.6 $91.15 1/29/20215,410,000 shares $395.63 million -9.1%N/A2.1 $73.13 1/15/20215,950,000 shares $469.51 million -20.0%N/A2.3 $78.91 12/31/20207,440,000 shares $538.21 million -16.5%N/A2.8 $72.34 12/15/20208,910,000 shares $693.82 million +28.0%N/A3.4 $77.87 11/30/20206,960,000 shares $491.03 million +10.5%N/A2.8 $70.55 11/15/20206,300,000 shares $455.81 million +22.8%N/A2.9 $72.35 10/30/20205,130,000 shares $398.70 million +19.9%N/A2.5 $77.72 10/15/20204,280,000 shares $343.73 million -4.7%N/A1.9 $80.31 9/30/20204,490,000 shares $348.78 million +5.9%N/A2 $77.68 9/15/20204,240,000 shares $334.83 million +3.9%N/A1.7 $78.97 8/31/20204,080,000 shares $306.49 million -8.9%N/A1.6 $75.12 8/14/20204,480,000 shares $326.23 million -6.5%N/A1.7 $72.82 7/31/20204,790,000 shares $293.10 million -27.3%N/A1.7 $61.19 HZNP Short Interest - Frequently Asked Questions What is Horizon Therapeutics Public's current short interest? Short interest is the volume of Horizon Therapeutics Public shares that have been sold short but have not yet been closed out or covered. As of September 15th, traders have sold 7,100,000 shares of HZNP short. Learn More on Horizon Therapeutics Public's current short interest. What is a good short interest ratio for Horizon Therapeutics Public? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HZNP shares currently have a short interest ratio of 3.0. Learn More on Horizon Therapeutics Public's short interest ratio. Is Horizon Therapeutics Public's short interest increasing or decreasing? Horizon Therapeutics Public saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 7,100,000 shares, a decrease of 25.1% from the previous total of 9,480,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Horizon Therapeutics Public's short interest compare to its competitors? Here is how the short interest of companies compare to Horizon Therapeutics Public: Bristol Myers Squibb Company (1.94%), Zoetis Inc. (0.00%), Royalty Pharma PLC (5.09%), Corcept Therapeutics Incorporated (12.21%), Jazz Pharmaceuticals PLC (10.16%), Perrigo Company plc (3.68%), Supernus Pharmaceuticals, Inc. (9.25%), Pacira BioSciences, Inc. (12.92%), Nektar Therapeutics (9.60%), Omeros Corporation (24.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($8.05 billion), T-Mobile US, Inc. ($3.94 billion), Charter Communications, Inc. ($3.77 billion), Occidental Petroleum Corporation ($3.27 billion), Tractor Supply Company ($2.29 billion), Celsius Holdings Inc. ($2.20 billion), Rivian Automotive, Inc. ($2.10 billion), Moderna, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($1.90 billion), and T. Rowe Price Group, Inc. ($1.90 billion). View all of the most shorted stocks. What does it mean to sell short Horizon Therapeutics Public stock? Short selling HZNP is an investing strategy that aims to generate trading profit from Horizon Therapeutics Public as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Horizon Therapeutics Public? A short squeeze for Horizon Therapeutics Public occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HZNP, which in turn drives the price of the stock up even further. How often is Horizon Therapeutics Public's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HZNP, twice per month. The most recent reporting period available is September, 15 2023. More Short Interest Resources from MarketBeat Related Companies BMY Short Interest Data ZTS Short Interest Data RPRX Short Interest Data CORT Short Interest Data JAZZ Short Interest Data PRGO Short Interest Data SUPN Short Interest Data PCRX Short Interest Data NKTR Short Interest Data OMER Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HZNP) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredSteve Jobs' Deathbed Secret Finally LeakedLeaked: Jobs’ Final Apple Project Exposed Bloomberg just leaked details of a secret project Steve Jobs set ...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Therapeutics Public Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Therapeutics Public With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HZNP Stock Alerts